Company intelligence / Profile preview

Farmasino Co., Ltd.

Ownership: Private
Employees: ~499
Development stage: Commercial

Overview

Farmasino operates one of China's largest production bases for fosfomycin products. It has over 400 catalogue products covering antibacterial, antiviral, anti-tuberculosis, anti-tumor drugs and more. The company provides R&D services from route scouting to scale-up synthesis under cGMP standards. Its facilities support both custom synthesis/CDMO work as well as large-scale commercial manufacturing.[1][2][3][5]

Therapeutic areas: OtherInfectious Diseases
Modalities: Small molecules (APIs, intermediates)Peptides (e.g. semaglutide)[7]
Industry: Contract Manufacturing Organization

Drug pipeline

1 asset

fosfomycin

Commercial

Indications: Bacterial infections

Partnerships

Strategic investors include Nanjing Industrial Fund, Qixia High-tech Zone Industrial Fund, Vazyme Biotech[5]. Collaborations with several well-known companies and research institutions are mentioned but not named specifically.

Beyond the preview

Go deeper on Farmasino Co., Ltd..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Farmasino Co., Ltd..

Explore the full profile